Biohaven Pharma (BHVN) Announces Strategic Collaboration with Pfizer (PFE) for Commercialization of Rimegepant Outside the US
Go back to Biohaven Pharma (BHVN) Announces Strategic Collaboration with Pfizer (PFE) for Commercialization of Rimegepant Outside the US| (NYSE: BHVN) | Delayed: 15.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.50 | 52 Week High | $ | |||
| Open | $15.50 | 52 Week Low | $ | |||
| Day High | $15.50 | P/E | N/A | |||
| Day Low | $15.50 | EPS | $ | |||
| Volume | 1,370 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.08 | 52 Week High | $37.39 | |||
| Open | $25.08 | 52 Week Low | $28.25 | |||
| Day High | $25.08 | P/E | 15.20 | |||
| Day Low | $25.08 | EPS | $1.65 | |||
| Volume | 105,148 | |||||
